Cancer Decisions - Free Newsletter -December 4, 2005

HERE AT THE MOSS REPORTS

A question that comes up very frequently in phone consultations with my clients is the issue of whether or not it is safe to take antioxidants while undergoing standard cancer treatments such as chemotherapy or radiation.

While there is mounting evidence to suggest that antioxidants are both safe and effective in counteracting the unpleasant side effects of chemotherapy and radiation, by and large the oncology profession tends to recommend strongly against the use of such supportive measures, citing concerns that antioxidants may interfere with the cancer-killing ability of standard treatments.

I have now written a full-length report on this topic, exposing the flaws in the arguments so often leveled against the use of antioxidants during cancer therapy. The report - Do Antioxidants And Chemotherapy Conflict? - is available for download from the Cancer Decisions web site: www.cancerdecisions.com at a cost of $9.95.

Also available from the Cancer Decisions web site is the full range of Moss Reports, a complete library of more than 200 individual reports, each one dealing with a different type of cancer and detailing in depth the best currently available conventional and alternative approaches to that particular cancer. You can order a Moss Report on your particular diagnosis and download it directly from our web site at www.cancerdecisions.com.

For those clients who are struggling with difficult treatment decisions I offer a phone consultation service. A phone consultation offers the chance to discuss the suggested treatment plan and examine all the various possible options. Many people find this service invaluable in coming to an informed choice. Jacqueline E. Johnson, RN is coordinator of the phone consultation service and can be contacted at: jacquie@cancerdecisions.com

We look forward to helping you.

INTRODUCING 'COMPLEMENTARY ONCOLOGY'

I have a new book coming out: "Complementary Oncology: Adjunctive Methods in the Treatment of Cancer." This is a textbook for health care workers, published by the American division of Thieme, an international scientific and medical publisher, which has produced high-quality products for physicians, scientists, technologists, students, and residents for nearly 120 years.

The book began as a German language textbook, edited by Joseph Beuth, MD, a tenured professor and director of the Institute for the Scientific Evaluation of Naturopathic Methods at the University of Cologne (founded in 1388). Dr. Beuth asked me to write a chapter for this book on the evaluation of conventional cancer treatments, along the lines of my book Questioning Chemotherapy, which had recently been published in German. After that book came out, and was well received, the publisher decided to produce an English-language version. They asked me to co-edit this book, and I agreed. We removed a few chapters, added some others, and generally streamlined the prose for a mainly American audience. To my knowledge, this is the first textbook in English on this important topic.

There are a total of 20 contributors, mostly Germans. The book offers insight into how a stratum of Middle European oncologists treats cancer in the 21st century. For example, here are some of the chapter headings:

--Tumor immunology by Volker Schirrmacher. Dr. Schirrmacher is a professor at the German Cancer Research Center in Heidelberg.

--Introduction to medical biometry by Ulrich Abel. Dr. Abel is also a professor at the University of Heidelberg. He will be remembered by some readers as author of the scholarly monograph, Chemotherapy of Advanced Epithelial Cancer (Hippokrates Verlag, Stuttgart, Germany, 1990).

--Cancer and nutrition by Heide Jenik and Rudolph van Leendert, colleagues of Dr. Beuth at Cologne University.

--Psycho-oncology by Karl Friedrich Klippel, MD, of the General Hospital in Celle (near Hannover). He is an active participant in the CAM cancer congress held each October-November at Medicine Week in Baden-Baden.

--The biological basis for using high dose multiple antioxidants as an adjunct to radiotherapy, chemotherapy, and experimental cancer therapies by Kedar N. Prasad, William C. Cole, Bipin Kuman and K. Che Prasad. Kedar Prasad recently retired from the University of Colorado where, for 25 years, he carried out laboratory research on this topic.

--Selenium in oncology by G.N. Schrauzer, professor at the research institute in Chula Vista, California.

--Proteolytic enzymes and lectin-standardized mistletoe extracts by Joseph Beuth, MD, who has carried out a number of clinical trials on this topic.

--Hyperthermia by E. Dieter Hager, MD, PhD, founding director of the BioMed Hospital of Bad Bergzabern, Germany.

--Applied complementary oncology by Josef Beuth, MD, a series of charts that make specific recommendations for the treatment of patients with a variety of cancer.

This is of course just a sample of the many chapters contained in this 292 page hardcover text. The list price is $99.95, but Amazon has it listed for $89.95. It can presently be preordered at this address:

http://buybox.amazon.com/exec/obidos/redirect?tag=cancerdecisio-20&link_code=xsc&creative=23424&camp=2025&path=/dt/assoc/tg/aa/xml/assoc/-/3131374519/cancerdecisio-20/ref=ac_bb6_,_amazon

Copies will ship as soon as they arrive in Amazon's warehouse, hopefully within the next few weeks.

--Ralph W. Moss, Ph.D.

**NOTE** To view this page in a more printable format, please CLICK HERE.

IMPORTANT DISCLAIMER

The news and other items in this newsletter are intended for informational purposes only. Nothing in this newsletter is intended to be a substitute for professional medical advice.